New Study Suggests U.S. COVID-19 Cases Could Have Been 35 Times Higher Without These Measures

The authors found the closing of entertainment businesses — such as restaurants, movie theaters and gyms — and shelter-in-place orders — such as Gov. Andy Beshear’s “Healthy at Home” initiative — resulted in a dramatic reduction in COVID-19 cases.

Read more

Mount Sinai Study Finds First Cases of COVID-19 in New York City are Primarily from European and US Sources

First definitive molecular epidemiology study of SARS-CoV-2 in New York City to describe the route by which the virus arrived

Read more

Global Team Enables Child With a Fatal Genetic Disease to Recover

A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.

Read more

Researchers Identify Potential Formula for Blood Cancer Vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.

Read more

Intermittent Fasting Increases Longevity in Cardiac Catheterization Patients

In a new study by researchers at the Intermountain Healthcare Heart Institute in Salt Lake City, researchers have found that cardiac catheterization patients who practiced regular intermittent fasting lived longer than patients who don’t.

Read more

New Research Could Change Clinical Practice for Cases of Unmanaged Heartburn

A study published today in The New England Journal of Medicine found that in patients seen for heartburn unresponsive to treatment with Proton Pump Inhibitors (PPIs), an extensive, systematic workup revealed truly PPI-refractory and reflux-related heartburn in only a minority of cases. In other words, most patients with heartburn unrelieved by PPIs did not have gastroesophageal reflux disease (GERD) causing the symptom. Furthermore, for the selected subgroup identified as having reflux-related, PPI-refractory heartburn, surgery that corrects reflux was significantly superior (67% success rate) to continued medical therapy (28% success rate).

Read more